Drug Discovery & Pharmaceuticals

RSS

Axxam and B'SYS Partner to Expand Access to Validated Ion Channel Cell Lines for High-Throughput Electrophysiology

Axxam S.p.A., a premier provider of integrated early drug discovery services, and B'SYS GmbH, a specialist in ion channel biology, are pleased to announce a strategic collaboration focused on enabling access to validated ion channel cell lines for hit and lead identification through high-throughput electrophysiological screening.

From Axxam S.p.A 8 Sep 2025

BioDlink Expands Ecosystem Alliance to Empower Biotech Innovators Worldwide

As BioDlink, a leading global CDMO, affirms its commitment to strategic alliances to support biotech innovation worldwide as it marks 15 years of operations.

From BioDlink 5 Sep 2025

Aptamer Signs Therapeutic Development Agreement with Invizius

Aptamer Group plc, the developer of next-generation synthetic binders for the life sciences industry, is pleased to announce that it has signed a new therapeutic development agreement with Invizius, a clinical-stage biotechnology company focused on second-generation complement system therapies for inflammatory, fibrotic, and autoimmune diseases.

From Aptamer Group 2 Sep 2025

GEMORNA Platform Generates Novel mRNA Sequences With Superior Drug Properties

Raina Biosciences Inc., ("Raina"), an mRNA technology and therapeutics company, today announced the publication of data from its generative AI platform in Science.

28 Aug 2025

Emory Chemists Boost Synthesis of Vinylic Ethers for Drug Discovery

A new approach to an established reaction boosts the ability to synthesize vinylic ethers - key building blocks for many molecules important to human health.

28 Aug 2025

Aptamer Group Introduces Novel Biomarker Discovery Service

Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science industry, today announced the launch of its biomarker discovery service, offering researchers in pharmaceutical, biotechnology, and diagnostic development an innovative approach to identify and validate new disease markers.

28 Aug 2025

Mitsui, QSimulate, and Quantinuum Launch “QIDO”: A Quantum-Integrated Chemistry Platform Targeting Faster Drug and Materials Discovery

Mitsui & Co., Ltd. (“Mitsui”), QSimulate, and Quantinuum today announced the launch of a new quantum-integrated chemistry platform, QIDO (Quantum-Integrated Discovery Orchestrator).

From Quantinuum Ltd 22 Aug 2025

Computational Modeling Creates a Database for Improved Detection of Designer Drugs

How do you identify something no one has a test for? Designer drugs replicate the effects of known, illicit drugs but evade law enforcement.

21 Aug 2025

New Molecules from the McMaster Greenhouse Target Drug-Resistant Fungi

A research team at McMaster University has discovered a new drug class that could someday lead to breakthrough treatments for dangerous fungal infections.

13 Aug 2025

Mapping T Cell Targets to Fight Coronaviruses and Beyond

Most vaccines are designed to provide immunity against just one pathogen. Vaccines for chicken pox (caused by varicella-zoster virus) were only developed to fight that one disease, for example.

8 Aug 2025

Chemists Discover Safer Way to Create Powerful Chemical Building Blocks

Chemists have developed a novel way to generate a variety of highly useful chemical building blocks by harnessing metal carbenes, suggests new research.

21 Jul 2025

Amino Acids Guide Cell Responses to Drugs Through a Complex Network

Amino acids play a fundamental role in regulating how cells respond to drugs. These molecules, which form proteins, act like bricks that communicate with each other within a structure.

17 Jul 2025

Vanderbilt and Parse Biosciences Join Forces to Accelerate Measles Antibody Discovery

Vanderbilt University Medical Center and Parse Biosciences, an innovator in single-cell sequencing, are collaborating on a new treatment to help unvaccinated measles victims, as the U.S. measles outbreak has now reached its highest case count in 30 years.

9 Jul 2025

New Stem Cell Reports Perspective: Biomanufacturing in Low Earth Orbit

A new perspective article just published in Stem Cell Reports, “Biomanufacturing in low Earth orbit: A paradigm shift,” features insights from the ISS National Laboratory’s very own Program Director for In-Space Biomanufacturing Davide Marotta, Deputy Chief Scientist Donna Roberts, and Chief Scientist Michael Roberts, as well as leading researchers in regenerative medicine.

3 Jul 2025

Fidelio Capital Partners with Alphalyse to Accelerate the Global Roll-Out of LC-MS Host Cell Protein Analytics

Alphalyse, a fast-growing Danish specialist contract research organization (CRO) that has developed GMP‑validated liquid‑chromatography mass‑spectrometry (LC‑MS) assays for host‑cell‑protein (HCP) impurity testing in biologic drugs, today announces that Fidelio Capital has acquired a majority stake in the company.

From Alphalyse A/S 2 Jul 2025

ColdBrew Enhances Accuracy of Protein Water Mapping for Drug Design

Every protein in the body is encased in a water shell that directs protein structure, provides vital stability and steers function.

30 Jun 2025

Bio-Rad Extends Anti-Idiotypic Antibody and SpyCatcher Reagent Ranges for Bioanalysis and Antibody Drug Development

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, today extended its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of antibodies specific to pertuzumab (Perjeta), guselkumab (Tremfya), canakinumab (Ilaris), belimumab (Benlysta), and the bispecific drug emicizumab (Hemlibra).

18 Jun 2025

Breakthrough Reaction Simplifies Synthesis of Bioactive Polycyclic Molecules

Organic chemistry features a wide array of reactions for creating complex molecules, among which the Diels–Alder reaction stands out for its versatility and precision.

17 Jun 2025

Unlocking Drug Discovery with SOAR's Innovative Resource

Northwestern's SOAR database enhances drug discovery by mapping gene activity, aiding researchers in identifying treatment targets and understanding diseases.

13 Jun 2025

New AI Model Predicts Drug and microRNA Interactions with High Accuracy

Scientists at Shaanxi Normal University have developed a new AI-driven model that can accurately predict interactions between microRNAs (miRNAs) and drugs, potentially speeding up the discovery of novel therapeutic targets and reducing the time and cost of drug development.

3 Jun 2025

Drug Discovery & Pharmaceuticals

Axxam and B'SYS Partner to Expand Access to Validated Ion Channel Cell Lines for High-Throughput Electrophysiology

BioDlink Expands Ecosystem Alliance to Empower Biotech Innovators Worldwide

Aptamer Signs Therapeutic Development Agreement with Invizius

GEMORNA Platform Generates Novel mRNA Sequences With Superior Drug Properties

Emory Chemists Boost Synthesis of Vinylic Ethers for Drug Discovery

Aptamer Group Introduces Novel Biomarker Discovery Service

Mitsui, QSimulate, and Quantinuum Launch “QIDO”: A Quantum-Integrated Chemistry Platform Targeting Faster Drug and Materials Discovery

Computational Modeling Creates a Database for Improved Detection of Designer Drugs

New Molecules from the McMaster Greenhouse Target Drug-Resistant Fungi

Mapping T Cell Targets to Fight Coronaviruses and Beyond

Chemists Discover Safer Way to Create Powerful Chemical Building Blocks

Amino Acids Guide Cell Responses to Drugs Through a Complex Network

Vanderbilt and Parse Biosciences Join Forces to Accelerate Measles Antibody Discovery

New Stem Cell Reports Perspective: Biomanufacturing in Low Earth Orbit

Fidelio Capital Partners with Alphalyse to Accelerate the Global Roll-Out of LC-MS Host Cell Protein Analytics

ColdBrew Enhances Accuracy of Protein Water Mapping for Drug Design

Bio-Rad Extends Anti-Idiotypic Antibody and SpyCatcher Reagent Ranges for Bioanalysis and Antibody Drug Development

Breakthrough Reaction Simplifies Synthesis of Bioactive Polycyclic Molecules

Unlocking Drug Discovery with SOAR's Innovative Resource

New AI Model Predicts Drug and microRNA Interactions with High Accuracy

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics